Pfizer Profit & Loss Annual

BSE: 500680 | NSE: PFIZER | ISIN: INE182A01018 | Sector: Major Drugs

4,783.00 -118.35 (-2.41%)Updated : 07 Aug 2026

Research on

Interim Data

Annual Data

Fiscal Period	2026	2025	2024	2023
Period End Date	Mar 26	Mar 25	Mar 24	Mar 23
Total Operating Expense	1,722.45	1,587.07	1,601.81	1,680.32
Other Net	186.00	0.95	36.30	8.02
Diluted Weighted Average Shares	4.57	4.57	4.58	4.58
Depreciation/ Amortization	57.73	60.79	62.28	104.02
Operating Income	797.20	694.28	591.36	744.44
Net Income	722.43	767.60	551.33	623.93
Income Availableto Com Excl Extra Ord	722.43	767.60	551.33	623.93
Other Operating Expenses Total	363.28	13.60	16.96	30.07
Net Income Before Taxes	975.67	1,016.09	746.07	824.01
Net Income After Taxes	722.43	767.60	551.33	623.93
Income Availableto Com Incl Extra Ord	722.43	767.60	551.33	623.93
Costof Revenue Total	884.31	859.11	842.01	927.65
Gross Profit	1,635.34	1,422.24	1,351.16	1,497.11
Interest Inc( Exp) Net- Non- Op Total	-7.53	149.58	121.46	71.50
Unusual Expense( Income)	49.16	-0.43	-7.95	-33.46
Diluted Net Income	722.43	767.60	551.33	623.93
DPS- Common Stock Primary Issue	75.00	35.00	35.00	35.00
Provisionfor Income Taxes	253.24	248.49	194.74	200.08
period Type	-	-	-	-
Net Income Before Extra Items	722.43	767.60	551.33	623.93
Total Revenue	2,519.65	2,281.35	2,193.17	2,424.76
period Length	12.00	12.00	12.00	12.00
Revenue	2,519.65	2,281.35	2,193.17	2,424.76
Selling/ General/ Admin Expenses Total	367.97	654.00	688.51	650.55
Diluted Normalized EPS	165.87	139.43	119.72	130.83
Diluted EPS Excluding Extra Ord Items	157.92	167.79	120.51	136.38
Gain( Loss)on Saleof Assets	-	171.28	-3.05	0.05
Interest Exp( Inc) Net- Operating Total	-	-	0.00	1.49

*All figures in crores except per share values

Trending Stocks

2,427.00+57.00(2.41%)

1,653.95+18.95(1.16%)

3,443.60+28.60(0.84%)

1,093.40-56.50 (-4.91%)

2,007.00-82.25 (-3.94%)

Related News